Massive study checks whooping cough vaccine safety in pregnant women
NCT ID NCT06258057
First seen Nov 20, 2025 · Last updated May 09, 2026 · Updated 21 times
Summary
This study looks at the safety of the Tdap5 vaccine (Adacel) given to pregnant women after 27 weeks of pregnancy. Researchers will compare over 365,000 vaccinated and unvaccinated mothers and their babies to see if there are any differences in pregnancy outcomes like preterm birth or low birth weight. The goal is to make sure the vaccine is safe for both mother and child.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS WHOOPING COUGH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site
Chilly-Mazarin, 91380, France
Conditions
Explore the condition pages connected to this study.